In type 1 diabetes, weekly basal insulin Fc was noninferior to daily insulin degludec for HbA<sub>1c</sub> at 26 wk.
Where this comes from
- Record sourced from PubMed, PMID 37399552.
- Also identified by DOI 10.7326/J23-0045.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Kazda CM, Bue-Valleskey JM, Chien J, et al. <b>Novel once-weekly basal insulin Fc achieved similar glycemic control with a safety profile comparable to insulin degludec in patients with type 1 diabetes.</b> Diabetes Care. 2023;46:1052-1059. 36920867.
Medical subject headings
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2